OpenVSafe by OpenVAERS
Search V-safe

AJK-22039-25058

3 vaccinations 2 coded responses 15 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
631 / MO
Registered
2022-01-25
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-05-06
    Dose 1 — Pfizer-BioNTech
  2. 2021-06-01
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-25
    Registered in v-safe
  4. 2022-01-25
    Dose 3 — Pfizer-BioNTech
  5. 2022-01-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  6. 2022-01-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: Feeling hot, Flushing — Feeling: Good · Fever
    Free text: Felt flushed/feverish but my temperature was normal
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-01-28
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  8. 2022-01-29
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Muscle or body aches, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  9. 2022-01-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Muscle or body aches, Abdominal pain
    Adult check-in
  10. 2022-01-31
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  11. 2022-02-01
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  12. 2022-02-08
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  13. 2022-02-15
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  14. 2022-02-22
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  15. 2022-03-01
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-03-08
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-04-26
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-07-26
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  19. 2023-01-25
    Survey response — 12 months, dose 3
    MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-05-06Pfizer-BioNTech No
22021-06-01Pfizer-BioNTech No
32022-01-25Pfizer-BioNTech No

Free text

Release 11 — days 1–6 daily, dose 3

2022-01-27

Systemic reaction (other): Felt flushed/feverish but my temperature was normal

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SROFeeling hot · · ✓
SROFlushing · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release